Skip to content

Bone Marrow Aspirate Concentration in Posterior Cervical Fusion

Bone Marrow Aspirate Concentration in Posterior Cervical Fusion

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02068547
Acronym
BMAC
Enrollment
8
Registered
2014-02-21
Start date
2014-02-28
Completion date
2017-04-05
Last updated
2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Myelopathy, Radiculopathy

Keywords

posterior cervical fusion, posterior cervical decompression

Brief summary

The purpose of this research is to test if that combining bone marrow aspirate (removing bone marrow with a needle) concentration with locally harvested (collected) autograft (patient's own bone from another part of the body) for use as the bone graft results in equal rates of a successful procedure (fusion), as compared to current best practice in high-risk patients undergoing posterior cervical fusion. Hypothesis: Bone marrow aspirate concentration combined with locally harvested autograft results in equivalent rates of bony fusion, as compared to current best practice in high-risk patients undergoing posterior cervical decompression and fusion.

Detailed description

100 consecutive high-risk patients who meet the following inclusion criteria: are 18-75 years of age, require a cervical spine MRI as part of their standard of care show evidence of CSM, and have cervical alignment allowing posterior instrumented fusion. High-risk will be defined as having a diagnosis of rheumatoid arthritis, osteoporosis, current smoker, or BMI \>30. Patients will be excluded if they have any MRI incompatible devices, have any prior cervical instrumentation, require an instrumented anterior cervical fusion, or have an underlying neurological condition affecting the cervical spine (MS, ALS, HIV). Patients will be sequentially randomized to one of two treatment groups. Group I, will receive current best practice for posterior instrumented fusion (locally harvested autograft, demineralized bone matrix, and cadaveric allograft). Group II, will receive locally harvested autograft and 20 cc of bone marrow aspirate concentration. To assist with analysis, we will collect information from patients' hematology results, obtained per their standard of care pre-operative workup. All patients will be treated post-operatively at the discretion of the treating surgeon. All patients will follow-up at 6 weeks, 3 months, 6 months, 12 months, and 24 months. At the 6, 12, and 24-month follow-up all patients will undergo flexion/extension X-rays, fusion will be defined as less than 2 mm or motion. A cervical spine CT may also be obtained at 24 months on all patients to assess fusion at the discretion of the treating surgeon. All radiographic assessments of fusion will be made by a Washington University staff radiologist, blinded to patient treatment.

Interventions

BIOLOGICALlocally harvested autograft, demineralized bone matrix, and cadaveric allograft
BIOLOGICALBone Marrow Aspirate

Sponsors

Harvest Technologies
CollaboratorINDUSTRY
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 75 * Have at least one of the following high risk qualifications: BMI \>30, Rheumatoid Arthritis, Osteoporosis, Current smoker * Able to cooperate in the completion of standardized outcome measures (multiple questionnaires) * Willing and able to comply with study protocol * Symptomatic cervical myelopathy and/or radiculopathy * Scheduled for cervical alignment, allowing management with a posterior approach

Exclusion criteria

* MRI incompatible device * History of prior cervical instrumentation * Requires an instrumented anterior cervical fusion * History of underlying neurological condition affecting the cervical spine (MS, Amyotrophic Lateral Sclerosis, HIV) * Pre-existent neurologic disorder or mental disorder that would preclude accurate evaluation (psychiatric disease, Parkinson's disease, Alzheimer's disease) * History of previous cervical fusion at the operative site * Pregnant * Active malignancy * Previous history of posterior cervical decompression

Design outcomes

Primary

MeasureTime frameDescription
Rate of Fusion6 months, 12 months, 24 monthsRate of fusion - (6, 12, and 24 months) Rate of fusion will be assessed by flexion extension X-rays at routine follow-up, translation method (\<2mm) and/or by computed tomography (CT) scan at 2 year post-operatively.

Secondary

MeasureTime frameDescription
Physical and Mental Health From Subject's Point of View24 monthsShort Form 36 (SF-36) is a profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index.
Neck Pain Affects Every Day Activities24 MonthsQuestionnaire that helps determine how a subject's neck pain affects their ability to manage every day activities.

Countries

United States

Participant flow

Participants by arm

ArmCount
Surigical Best Practice
Group 1 will receive current best practice for posterior instrumented fusion (locally harvested autograft, demineralized bone matrix, and cadaveric allograft) locally harvested autograft, demineralized bone matrix, and cadaveric allograft
4
Group 2
Group II, will receive locally harvested autograft and 20 cc of bone marrow aspirate concentration. Bone Marrow Aspirate
4
Total8

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up33
Overall StudyPhysician Decision10

Baseline characteristics

CharacteristicSurigical Best PracticeGroup 2Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
3 Participants4 Participants7 Participants
Age, Continuous53.09 years59.75 years56.42 years
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants4 Participants8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants1 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
2 Participants3 Participants5 Participants
Region of Enrollment
United States
4 participants4 participants8 participants
Sex: Female, Male
Female
1 Participants1 Participants2 Participants
Sex: Female, Male
Male
3 Participants3 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 40 / 4
other
Total, other adverse events
0 / 40 / 4
serious
Total, serious adverse events
0 / 40 / 4

Outcome results

Primary

Rate of Fusion

Rate of fusion - (6, 12, and 24 months) Rate of fusion will be assessed by flexion extension X-rays at routine follow-up, translation method (\<2mm) and/or by computed tomography (CT) scan at 2 year post-operatively.

Time frame: 6 months, 12 months, 24 months

Population: Study was discontinued prior to data being analyzed.

Secondary

Neck Pain Affects Every Day Activities

Questionnaire that helps determine how a subject's neck pain affects their ability to manage every day activities.

Time frame: 24 Months

Population: Study was discontinued prior to data being analyzed.

Secondary

Physical and Mental Health From Subject's Point of View

Short Form 36 (SF-36) is a profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index.

Time frame: 24 months

Population: Study was discontinued prior to data being analyzed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026